American Century Companies’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-67,329
| Closed | -$147K | – | 2961 |
|
2024
Q4 | $147K | Buy |
67,329
+7,414
| +12% | +$16.2K | ﹤0.01% | 2814 |
|
2024
Q3 | $131K | Buy |
59,915
+34,032
| +131% | +$74.2K | ﹤0.01% | 2815 |
|
2024
Q2 | $59.8K | Buy |
+25,883
| New | +$59.8K | ﹤0.01% | 2851 |
|
2024
Q1 | – | Sell |
-476,542
| Closed | -$1.18M | – | 2966 |
|
2023
Q4 | $1.18M | Buy |
476,542
+228,640
| +92% | +$565K | ﹤0.01% | 1993 |
|
2023
Q3 | $8.61M | Sell |
247,902
-2,323
| -0.9% | -$80.7K | 0.01% | 1118 |
|
2023
Q2 | $8.21M | Buy |
250,225
+1,037
| +0.4% | +$34K | 0.01% | 1137 |
|
2023
Q1 | $8.33M | Sell |
249,188
-46,900
| -16% | -$1.57M | 0.01% | 1082 |
|
2022
Q4 | $9.71M | Sell |
296,088
-2,090
| -0.7% | -$68.5K | 0.01% | 982 |
|
2022
Q3 | $10.4M | Sell |
298,178
-124,607
| -29% | -$4.35M | 0.01% | 883 |
|
2022
Q2 | $5.17M | Buy |
422,785
+29,916
| +8% | +$366K | ﹤0.01% | 1108 |
|
2022
Q1 | $5.33M | Buy |
392,869
+119
| +0% | +$1.62K | ﹤0.01% | 1095 |
|
2021
Q4 | $7.8M | Buy |
+392,750
| New | +$7.8M | ﹤0.01% | 947 |
|